Stay updated on Avelumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Solid Tumors Clinical Trial page.

Latest updates to the Avelumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a small update to the page's version metadata rather than a substantive change to the study details or layout.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Adrenal cortex carcinoma and Squamous cell carcinoma of the head and neck to the study page’s condition list, aligning with ACC and HNSCC expansion cohorts.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check90 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding lapse notice and older Revision: v3.4.1; no study content or outcomes were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Avelumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Solid Tumors Clinical Trial page.